Skip to main content
All lobbying filings

SACHEM STRATEGIES

Lobbying for STRAND THERAPEUTICS · mRNA therapeutics company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $20,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to biomanufacturing policy (no specific legislation).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem